
Neumitra
Neumitra develops connected technologies to address the effects of stress on brain health and performance.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor | €0.0 | round | |
N/A | Debt | ||
Total Funding | 000k |
Related Content
Neumitra was a Boston-based company focused on quantifying and managing stress through wearable technology and data analytics. Founded in 2009 by neuroscientist Robert Goldberg, biotechnologist Anand Yadav, and algorithms engineer Safiyy Momen, the company emerged from an MIT Neurotechnology Ventures class. The founders' diverse backgrounds in neuroscience, biotech, and engineering converged to address what they identified as a significant unmet need in managing the physiological and psychological impacts of stress, which they estimated to cost the U.S. economy billions in lost productivity and healthcare expenses.
The company's core offering consisted of wearable sensors and analytics software designed to measure autonomic nervous system activity in real-time. Initially developing its own hardware, such as the "Bandu" and later the "Neuma BioWatch," Neumitra's strategy evolved to focus on creating biomodules and software that could be integrated into a wide variety of third-party wearables like smartwatches and fitness bracelets. This pivot acknowledged the difficulty of competing in the hardware market and the desire to collect data from a broader user base. The sensors primarily tracked electrodermal activity (EDA), or skin conductance, along with motion and temperature, to detect physiological signs of stress.
This data was transmitted to a mobile application that provided users with real-time feedback, often through a simple color-gradient scale or a vibration alert, to signal rising stress levels. A key aspect of the platform was its ability to integrate this physiological data with contextual information from a user's smartphone, such as calendar appointments and GPS location, to help identify specific triggers for stress. The business model appeared to have multiple facets, including a consulting business to help large organizations monitor and analyze workforce stress, direct-to-consumer device sales, and the licensing of its analytics and biomodule technology to other device manufacturers. Neumitra also engaged in ambitious research projects, such as a large-scale study in Boston to map the city's stress dynamics. The company's work attracted early investments from entities like Rock Health, Peter Thiel's Breakout Labs, and MassChallenge. However, according to market intelligence, Neumitra is now considered a deadpooled company. Keywords: neurotechnology, stress management, wearable sensors, biometric data, electrodermal activity, EDA, mental wellness, digital health, affective computing, biofeedback, stress analytics, physiological monitoring, contextual data, corporate wellness, mobile health, autonomic nervous system, behavioral health, data analytics, biosensors, human performance